Asphyxiating thoracic dysplasia 3
Asphyxiating thoracic dysplasia 3 (ATD3), also known as Jeune syndrome, is a rare genetic disorder characterized by a narrow thorax, short ribs, shortened limbs, and other skeletal abnormalities. The condition is inherited in an autosomal recessive manner, meaning both copies of the gene in each cell must have mutations for the individual to be affected.
Etiology[edit | edit source]
ATD3 is caused by mutations in the IFT80 gene. This gene provides instructions for making a protein that is part of the intraflagellar transport system, which is essential for the formation and maintenance of cilia. Cilia are microscopic, finger-like projections that stick out from the surface of cells and are involved in cell movement and signaling.
Clinical Features[edit | edit source]
Individuals with ATD3 typically present with a narrow, bell-shaped thorax with short ribs and various other skeletal abnormalities such as polydactyly (extra fingers or toes), short limbs, and pelvic dysplasia. These skeletal abnormalities can lead to life-threatening complications in infancy, including respiratory distress and renal failure.
Diagnosis[edit | edit source]
Diagnosis of ATD3 is based on clinical features, radiographic findings, and can be confirmed by genetic testing identifying a mutation in the IFT80 gene. Prenatal diagnosis is possible if the disease-causing mutations in the family are known.
Treatment[edit | edit source]
There is currently no cure for ATD3. Treatment is supportive and based on the signs and symptoms present in each individual. Management may include respiratory support, renal replacement therapy for those with renal failure, and orthopedic interventions for skeletal abnormalities.
Prognosis[edit | edit source]
The prognosis for individuals with ATD3 varies. Some individuals may not survive infancy due to severe respiratory distress. Others may live into adulthood with careful management of respiratory and renal complications.
See Also[edit | edit source]
NIH genetic and rare disease info[edit source]
Asphyxiating thoracic dysplasia 3 is a rare disease.
.svg){kind=icon} | This pediatrics article is a stub. You can help WikiMD by expanding it. |
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
